EGFR and glioblastoma: To demonstrate effects of antitussive compounds on the growth of glioblastoma cell lines, we used U87MG, temozolomide-resistant U87MG-TMZR, lapatinib (EGFR inhibitor)-resistant U87MG-LAPAR, and chemoresistant T98G.